Mingshu Wang Selected Research

Flavivirus Infections

1/2022	Flaviviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.
6/2021	Structure and function of capsid protein in flavivirus infection and its applications in the development of vaccines and therapeutics.
10/2020	The role of capsid in the flaviviral life cycle and perspectives for vaccine development.
1/2020	cis-Acting Sequences and Secondary Structures in Untranslated Regions of Duck Tembusu Virus RNA Are Important for Cap-Independent Translation and Viral Proliferation.
1/2020	Binding of Duck Tembusu Virus Nonstructural Protein 2A to Duck STING Disrupts Induction of Its Signal Transduction Cascade To Inhibit Beta Interferon Induction.
1/2018	Conserved Active-Site Residues Associated with OAS Enzyme Activity and Ubiquitin-Like Domains Are Not Required for the Antiviral Activity of goOASL Protein against Avian Tembusu Virus.
11/2017	Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections.
1/2017	Goose Mx and OASL Play Vital Roles in the Antiviral Effects of Type I, II, and III Interferon against Newly Emerging Avian Flavivirus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mingshu Wang Research Topics

Disease

80	Infections 07/2022 - 06/2008
40	Enteritis 01/2021 - 06/2008
32	Virus Diseases (Viral Diseases) 05/2022 - 01/2010
31	Plague (Bubonic Plague) 07/2022 - 04/2010
8	Flavivirus Infections 01/2022 - 01/2017
7	Bites and Stings (Sting) 03/2022 - 01/2018
5	Melanoma (Melanoma, Malignant) 03/2022 - 09/2013
5	Influenza in Birds (Avian Flu) 01/2017 - 05/2014
3	Viremia 05/2022 - 05/2015
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 11/2021 - 08/2015
3	Neoplasms (Cancer) 01/2021 - 01/2020
3	Herpes Simplex 01/2020 - 11/2015
2	Body Weight (Weight, Body) 03/2015 - 12/2010
1	Cholera 03/2022
1	Inflammation (Inflammations) 01/2022
1	Coinfection 08/2021
1	Vesicular Stomatitis 05/2021
1	Diarrhea 04/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Persistent Infection 01/2021
1	Reinfection 01/2020

Drug/Important Bio-Agent (IBA)

59	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2009
27	Antiviral Agents (Antivirals)IBA 05/2022 - 01/2015
18	VaccinesIBA 05/2022 - 02/2009
15	Messenger RNA (mRNA)IBA 07/2022 - 05/2011
13	RNA (Ribonucleic Acid)IBA 07/2022 - 01/2014
13	InterferonsIBA 03/2022 - 05/2014
11	Glycoproteins (Glycoprotein)IBA 06/2021 - 07/2010
10	CytokinesIBA 01/2022 - 12/2014
9	butyl phosphorotrithioate (DEF)IBA 07/2022 - 09/2009
9	AntibodiesIBA 05/2022 - 10/2009
7	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 06/2008
7	AntigensIBA 04/2021 - 10/2009
6	Viral ProteinsIBA 01/2022 - 01/2019
6	Interferon Type IIBA 11/2020 - 01/2016
5	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2012
5	ParaffinIBA 03/2011 - 04/2009
4	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 11/2017
4	Capsid Proteins (Capsid Protein)IBA 06/2021 - 08/2015
4	Staphylococcal Protein A (Protein A)IBA 01/2021 - 01/2017
4	paraform (paraformaldehyde)IBA 03/2011 - 04/2009
3	Biological ProductsIBA 05/2022 - 01/2017
3	Phosphotransferases (Kinase)IBA 03/2022 - 01/2020
3	Poly I-CIBA 01/2022 - 01/2016
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020 - 05/2014
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 05/2014
3	DNA VaccinesIBA 01/2018 - 07/2012
3	Pattern Recognition ReceptorsIBA 01/2017 - 08/2015
3	ODN2006IBA 01/2017 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 03/2016 - 12/2014
3	ImmunosorbentsIBA 12/2011 - 10/2009
3	EnzymesIBA 12/2011 - 10/2009
2	Caspase 3 (Caspase-3)IBA 07/2022 - 01/2022
2	Attenuated VaccinesIBA 03/2022 - 01/2018
2	CaspasesIBA 01/2022 - 01/2019
2	3' Untranslated Regions (3' UTR)IBA 01/2022 - 01/2020
2	Interleukin-2 (IL2)IBA 11/2021 - 12/2014
2	Complementary DNA (cDNA)IBA 01/2021 - 01/2018
2	Suppressor of Cytokine Signaling ProteinsIBA 01/2021 - 01/2020
2	Viral RNAIBA 11/2020 - 01/2020
2	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2020 - 01/2019
2	OligodeoxyribonucleotidesIBA 01/2019 - 03/2016
2	Complement System Proteins (Complement)IBA 10/2018 - 12/2011
2	NucleotidesIBA 12/2017 - 05/2012
2	A-Form DNA (A-DNA)IBA 12/2016 - 05/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 12/2010
2	2',5'-Oligoadenylate Synthetase (2',5' Oligoadenylate Synthetase)IBA 12/2014 - 05/2014
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2014 - 02/2012
2	Immune Sera (Antisera)IBA 05/2014 - 04/2010
2	herpes simplex virus type 1 glycoprotein gCIBA 05/2011 - 11/2010
1	Long Noncoding RNAIBA 07/2022
1	Cytochromes c (Cytochrome c)IBA 07/2022
1	Death Domain ReceptorsIBA 07/2022
1	Apoptosis Regulatory ProteinsIBA 07/2022
1	Matrix Metalloproteinases (MMPs)IBA 07/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022
1	Interferon Regulatory FactorsIBA 03/2022
1	6-methyladenineIBA 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	Small Untranslated RNAIBA 01/2022
1	Interleukin-4 (Interleukin 4)IBA 11/2021
1	SC75741IBA 05/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Interleukin-7 (Interleukin 7)IBA 01/2021
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 01/2021
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 01/2021
1	LipidsIBA 01/2021
1	LuciferasesIBA 01/2021
1	Adenovirus VaccinesIBA 12/2020
1	Salmonella VaccinesIBA 12/2020
1	Transfer RNA (tRNA)IBA 11/2020
1	Carbapenems (Carbapenem Antibiotics)IBA 07/2020
1	PolyubiquitinIBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	Toll-Like Receptor 3IBA 01/2020

Therapy/Procedure

7	Therapeutics 06/2021 - 01/2015
1	Drug Therapy (Chemotherapy) 01/2021